Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

The Impact of Aminoacid Substitution at Position 116 Class I HLA, in Unrelated Donor Transplants

Patrizia Chiusolo, Teresa Lamparelli, Giuseppe Sapienza, MD, Alida Dominietto, MD, Anna Maria Raiola, MD, Carmen Di Grazia, MD, Sabrina Giammarco, MD PhD, Francesca Gualandi, Elisabetta Metafuni, Monica Rossi, Gessica Minnella, Simona Sica, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2019) 134 (Supplement_1): 4620.

https://doi.org/10.1182/blood-2019-130614

Published: 2019

Journal Articles

Full Donor Chimerism after Allografts for Myelofibrosis: The Role of Conditioning Regimen

Patrizia Chiusolo, Sabrina Giammarco, MD PhD, Teresa Lamparelli, Lucia Casarino, Monica Rossi, Alida Dominietto, MD, Anna Maria Raiola, MD, Francesca Gualandi, Carmen Di Grazia, MD, Silvia Betti, MD PhD, Federica Sorà, MD, Elena Rossi, MD PhD, Luciana Teofili, MD, Simona Sica, MD, Andrea Bacigalupo, MD, Emanuele Angelucci, MD

Blood (2019) 134 (Supplement_1): 4490.

https://doi.org/10.1182/blood-2019-126711

Published: 2019

Journal Articles

Unrelated Cord Blood Transplantation and Post-Transplant Cyclophosphamide (PT-CY)

Patrizia Chiusolo, Andrea Bacigalupo, MD, Simona Sica, MD, Sabrina Giammarco, MD PhD, Elisabetta Metafuni, Federica Sora, MD, Luca Laurenti, MD, Francesco Autore, MD, Idanna Innocenti, MD PhD, Silvia Bellesi, Gina Zini, MD PhD, Maria Bianchi, Caterina Giovanna Valentini, Luciana Teofili, MD

Blood (2019) 134 (Supplement_1): 3332.

https://doi.org/10.1182/blood-2019-130849

Published: 2019

Journal Articles

Unmanipulated Haploidentical Marrow Transplantation with a Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen: An Update on 444 Patients

Andrea Bacigalupo, MD, Anna Maria Raiola, MD, Alida Dominietto, MD, Carmen Di Grazia, MD, Stefania Bregante, Francesca Gualandi, Maria Teresa Van Lint, MD, Patrizia Chiusolo, MD, Luca Laurenti, MD, Federica Sora, Sabrina Giammarco, MD PhD, Simona Sica, MD, Emanuele Angelucci, MD

Blood (2018) 132 (Supplement 1): 3351.

https://doi.org/10.1182/blood-2018-99-118850

Published: 2018

Journal Articles

EARLY Post-Transplant Events , Cost of Admission and Mortality, in Patients Undergoing Allogeneic Transplants from Identical Siblings, Unrelated Donors or Haploidentical Donors

Federica SORA, MD, Patrizia Chiusolo, MD, Luca Laurenti, MD, Sabrina Giammarco, MD PhD, Francesco Autore, MD, Idanna Innocenti, MD PhD, Simona Sica, MD, Metafuni Elisabetta, Andrea Bacigalupo, MD

Blood (2018) 132 (Supplement 1): 4648.

https://doi.org/10.1182/blood-2018-99-116506

Published: 2018

Journal Articles

Eltrombopag for the Treatment of Aplastic Anemia in Europe

Blood (2018) 132 (Supplement 1): 1304.

https://doi.org/10.1182/blood-2018-99-116363

Published: 2018

Journal Articles

Transplant Outcome for Patients with Acquired Aplastic Anemia over the Age of 40: Mortality HAS NOT Been Reduced in 2015

Sabrina Giammarco, MD PhD, Simona Sica, MD, Carlo Dufour, MD, Regis Peffault De Latour, MD PhD, Gerard Socie, MD PhD, Jakob R. Passweg, MDMS, Andrea Bacigalupo, MD

Blood (2017) 130 (Supplement 1): 3326.

https://doi.org/10.1182/blood.V130.Suppl_1.3326.3326

Published: 2017

Journal Articles

UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen

Patrizia Chiusolo, Angelo Minucci, Metafuni Elisabetta, Sabrina Giammarco, MD PhD, Monica Rossi, Gessica Minnella, Cecilia Zuppi, Andrea Urbani, Andrea Bacigalupo, MD, Ettore Capoluongo, Simona Sica, MD

Blood (2017) 130 (Supplement 1): 3218.

https://doi.org/10.1182/blood.V130.Suppl_1.3218.3218

Published: 2017

NARROW

The Impact of Aminoacid Substitution at Position 116 Class I HLA, in Unrelated Donor Transplants

Full Donor Chimerism after Allografts for Myelofibrosis: The Role of Conditioning Regimen

Unrelated Cord Blood Transplantation and Post-Transplant Cyclophosphamide (PT-CY)

Unmanipulated Haploidentical Marrow Transplantation with a Modified Post-Transplant Cyclophosphamide (PT-CY) Regimen: An Update on 444 Patients

EARLY Post-Transplant Events , Cost of Admission and Mortality, in Patients Undergoing Allogeneic Transplants from Identical Siblings, Unrelated Donors or Haploidentical Donors

Eltrombopag for the Treatment of Aplastic Anemia in Europe

Transplant Outcome for Patients with Acquired Aplastic Anemia over the Age of 40: Mortality HAS NOT Been Reduced in 2015

UGT1A1 Polymorphism and Mortality Outcome after Allogeneic Stem Cell Transplantation with Busulfan Based Regimen

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only